PAM
MGNX icon

Paradigm Asset Management’s MacroGenics MGNX Stock Holding History

Paradigm Asset Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-600
Closed -$16.2K – 730
2016
Q2 		$16.2K Hold
600
– – ﹤0.01% 742
2016
Q1 		$11.3K Sell
600
-1,300
-68% -$24.8K ﹤0.01% 782
2015
Q4 		$58.8K Buy
1,900
+250
+15% +$7.59K 0.01% 610
2015
Q3 		$35.3K Buy
+1,650
New +$51.8K ﹤0.01% 711

Other funds holding MGNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BRC
Blue Ridge Capital New York $215M AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Paradigm Asset Management's MGNX Position: Q3 2016 in Review

Paradigm Asset Management sold out of MacroGenics (MGNX) in Q3 2016, closing a stake of 600 shares — an estimated $16.2K sold.

Paradigm Asset Management first reported a position in MGNX in Q3 2015 and held it in 4 quarters. The position peaked at $58.8K in Q4 2015. 132 funds tracked by Wall St. Rank hold MGNX as of Q3 2016.

  • Paradigm Asset Management reported no remaining MacroGenics position as of Q3 2016 after selling out during the quarter.
  • Paradigm Asset Management sold 600 MacroGenics shares in Q3 2016, an estimated $16.2K.
  • Paradigm Asset Management first reported a position in MacroGenics in Q3 2015 and held it in 4 quarters.
  • Paradigm Asset Management's MacroGenics position peaked at $58.8K in Q4 2015.
  • 132 funds tracked by Wall St. Rank held MacroGenics as of Q3 2016.

Based on Paradigm Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.